Canna~Fangled Abstracts CBD Gel for Fragile X: Ongoing Open-Label Results Clinical Trial Neurology. 2025 Apr 8;104(7_Supplement_1):2238. doi: 10.1212/WNL.0000000000209008. Epub 2025 Apr 7. Long-term Safety and Effectiveness…Freedom WaresApril 7, 2025
Canna~Fangled Abstracts Treatment of Neuropsychiatric Symptoms in Alzheimer’s Disease with a Cannabis-Based Magistral Formulation: An Open-Label Prospective Cohort Study As a library, NLM provides access to scientific literature. Inclusion in an NLM database does…Freedom WaresSeptember 12, 2024
Canna~Fangled Abstracts Using THC Edible Gummies for Behavioral Symptoms of Dementia: Reply to Goldman and Markov LETTER TO THE EDITOR Erin K. Zahradnik, MD, and Cristian Hernandez, BSc Published: June 5, 2024…Freedom WaresJune 10, 2024
Canna~Fangled Abstracts Cannabinoids for Behavioral Symptoms in Dementia: An Overview Pharmacopsychiatry. 2024 Mar 6. doi: 10.1055/a-2262-7837. Online ahead of print. Barbara Broers 1, Federica Bianchi 2 Affiliations expand PMID: 38447959…Freedom WaresMarch 6, 2024